BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28316234)

  • 1. Modeling Exposure in the Tox21 in Vitro Bioassays.
    Fischer FC; Henneberger L; König M; Bittermann K; Linden L; Goss KU; Escher BI
    Chem Res Toxicol; 2017 May; 30(5):1197-1208. PubMed ID: 28316234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Toxicity and Volatility Cutoff in Reporter Gene Assays Used for High-Throughput Screening.
    Escher BI; Glauch L; König M; Mayer P; Schlichting R
    Chem Res Toxicol; 2019 Aug; 32(8):1646-1655. PubMed ID: 31313575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.
    Qin W; Henneberger L; Huchthausen J; König M; Escher BI
    Environ Int; 2023 Mar; 173():107857. PubMed ID: 36881956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of freely dissolved effect concentrations in in vitro cell-based bioassays.
    Henneberger L; Mühlenbrink M; König M; Schlichting R; Fischer FC; Escher BI
    Arch Toxicol; 2019 Aug; 93(8):2295-2305. PubMed ID: 31230094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Exposure Assessment of Ionizable Organic Chemicals in
    Huchthausen J; Mühlenbrink M; König M; Escher BI; Henneberger L
    Chem Res Toxicol; 2020 Jul; 33(7):1845-1854. PubMed ID: 32368900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C18-Coated Solid-Phase Microextraction Fibers for the Quantification of Partitioning of Organic Acids to Proteins, Lipids, and Cells.
    Henneberger L; Mühlenbrink M; Fischer FC; Escher BI
    Chem Res Toxicol; 2019 Jan; 32(1):168-178. PubMed ID: 30585484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Validation of Mass Balance Models for in Vitro Cell-Based Bioassays.
    Henneberger L; Mühlenbrink M; Heinrich DJ; Teixeira A; Nicol B; Escher BI
    Environ Sci Technol; 2020 Jan; 54(2):1120-1127. PubMed ID: 31852189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Headspace-free setup of in vitro bioassays for the evaluation of volatile disinfection by-products.
    Stalter D; Dutt M; Escher BI
    Chem Res Toxicol; 2013 Nov; 26(11):1605-14. PubMed ID: 24117097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bioavailability on the correlation between in vitro cytotoxic and in vivo acute fish toxic concentrations of chemicals.
    Gülden M; Seibert H
    Aquat Toxicol; 2005 May; 72(4):327-37. PubMed ID: 15848252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Realistic Dosimetry
    Dimitrijevic D; Fabian E; Nicol B; Funk-Weyer D; Landsiedel R
    Chem Res Toxicol; 2022 Nov; 35(11):1962-1973. PubMed ID: 36264934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity Burst? Differentiating Specific from Nonspecific Effects in Tox21
    Escher BI; Henneberger L; König M; Schlichting R; Fischer FC
    Environ Health Perspect; 2020 Jul; 128(7):77007. PubMed ID: 32700975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Chemicals in Reporter Gene Bioassays with Different Metabolic Activities Compared to Baseline Toxicity.
    Huchthausen J; Braasch J; Escher BI; König M; Henneberger L
    Chem Res Toxicol; 2024 May; 37(5):744-756. PubMed ID: 38652132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How To Improve the Dosing of Chemicals in High-Throughput
    Fischer FC; Henneberger L; Schlichting R; Escher BI
    Chem Res Toxicol; 2019 Aug; 32(8):1462-1468. PubMed ID: 31328914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect-based trigger values for in vitro bioassays: Reading across from existing water quality guideline values.
    Escher BI; Neale PA; Leusch FD
    Water Res; 2015 Sep; 81():137-48. PubMed ID: 26057261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein and lipid binding parameters in rainbow trout (Oncorhynchus mykiss) blood and liver fractions to extrapolate from an in vitro metabolic degradation assay to in vivo bioaccumulation potential of hydrophobic organic chemicals.
    Escher BI; Cowan-Ellsberry CE; Dyer S; Embry MR; Erhardt S; Halder M; Kwon JH; Johanning K; Oosterwijk MT; Rutishauser S; Segner H; Nichols J
    Chem Res Toxicol; 2011 Jul; 24(7):1134-43. PubMed ID: 21604782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining and Controlling Exposure During In Vitro Toxicity Testing and the Potential of Passive Dosing.
    Smith KEC; Schäfer S
    Adv Biochem Eng Biotechnol; 2017; 157():263-292. PubMed ID: 27406186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Experimental Polystyrene Partition Constants and Diffusion Coefficients to Predict the Sorption of Neutral Organic Chemicals to Multiwell Plates in in Vivo and in Vitro Bioassays.
    Fischer FC; Cirpka OA; Goss KU; Henneberger L; Escher BI
    Environ Sci Technol; 2018 Nov; 52(22):13511-13522. PubMed ID: 30298728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative endpoint sensitivity of in vitro estrogen agonist assays.
    Dreier DA; Connors KA; Brooks BW
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):185-93. PubMed ID: 25896097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Membrane Concentration and Mass-Balance Model to Identify Baseline Cytotoxicity of Hydrophobic and Ionizable Organic Chemicals in Mammalian Cell Lines.
    Lee J; Braun G; Henneberger L; König M; Schlichting R; Scholz S; Escher BI
    Chem Res Toxicol; 2021 Sep; 34(9):2100-2109. PubMed ID: 34357765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.